{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:48:21Z","timestamp":1780735701537,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004398","name":"Mitsubishi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016925","name":"Takeda Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.steroids.2020.108748","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T02:46:46Z","timestamp":1603334806000},"page":"108748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Circulating steroids and mood disorders in patients with polycystic ovary syndrome"],"prefix":"10.1016","volume":"165","author":[{"given":"Tomoko","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguhiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Miyado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2020.108748_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam, ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2020.108748_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2016.02.010","article-title":"Steroidogenic pathways involved in androgen biosynthesis in eumenorrheic women and patients with polycystic ovary syndrome","volume":"158","author":"Saito","year":"2016","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2020.108748_b0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2020.108748_b0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.steroids.2020.108748_b0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.fertnstert.2009.09.025","article-title":"Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)","volume":"94","author":"Bhattacharya","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2020.108748_b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0301-0082(92)90025-A","article-title":"Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance","volume":"38","author":"Majewska","year":"1992","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.steroids.2020.108748_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","article-title":"The role of allopregnanolone in depression and anxiety","volume":"113","author":"Schule","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.steroids.2020.108748_b0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pneurobio.2013.07.005","article-title":"Allopregnanolone and mood disorders","volume":"113","author":"B\u00e4ckstr\u00f6m","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.steroids.2020.108748_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09540261.2018.1553775","article-title":"Allopregnanolone and reproductive psychiatry: an overview","volume":"31","author":"McEvoy","year":"2019","journal-title":"Int. Rev. Psychiatry."},{"key":"10.1016\/j.steroids.2020.108748_b0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cen.12809","article-title":"Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone","volume":"83","author":"Hedstrom","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.steroids.2020.108748_b0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpsychores.2013.01.002","article-title":"Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome","volume":"74","author":"Annagur","year":"2013","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.steroids.2020.108748_b0060","first-page":"356","article-title":"Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls","volume":"66","author":"Weiner","year":"2004","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.steroids.2020.108748_b0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2020.108748_b0070","series-title":"Obesity: Preventing and Managing The Global Epidemic","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.steroids.2020.108748_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humupd\/dmp024","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz","year":"2010","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.steroids.2020.108748_b0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-4362.1997.00099.x","article-title":"A comparison of current acne grading systems and proposal of a novel system","volume":"36","author":"Doshi","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.steroids.2020.108748_b0085","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2020.108748_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.steroids.2020.108748_b0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.steroids.2020.108748_b0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2020.108748_b0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.0.1450749","article-title":"Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years","volume":"145","author":"Bili","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.steroids.2020.108748_b0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1530\/EC-19-0496","article-title":"Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age","volume":"9","author":"de Medeiros","year":"2020","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.steroids.2020.108748_b0115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.steroids.2020.108748_b0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.mog.0000126135.73066.89","article-title":"Depression and insulin resistance: applications to polycystic ovary syndrome","volume":"47","author":"Brown","year":"2004","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2020.108748_b0125","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.fertnstert.2009.09.018","article-title":"Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation","volume":"93","author":"Deeks","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2020.108748_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mpr.138","article-title":"The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys","volume":"12","author":"Andrade","year":"2003","journal-title":"Int. J. Methods. Psychiatr. Res."},{"key":"10.1016\/j.steroids.2020.108748_b0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0306-4530(00)00023-8","article-title":"Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression","volume":"25","author":"Weber","year":"2000","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.steroids.2020.108748_b0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijpsycho.2012.03.001","article-title":"Sex steroid levels temporarily increase in response to acute psychosocial stress in healthy men and women","volume":"84","author":"Lennartsson","year":"2012","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.steroids.2020.108748_b0145","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1111\/j.1460-9568.2012.08194.x","article-title":"High serum androstenedione levels correlate with impaired memory in the surgically menopausal rat: a replication and new findings","volume":"36","author":"Camp","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.steroids.2020.108748_b0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.ijo.0803406","article-title":"High basal serum allopregnanolone levels in overweight girls","volume":"31","author":"Predieri","year":"2007","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.steroids.2020.108748_b0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yfrne.2017.07.002","article-title":"Allopregnanolone involvement in feeding regulation, overeating and obesity","volume":"48","author":"Holmberg","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.steroids.2020.108748_b0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1024587217927","article-title":"Psychoendocrinological assessment of the menstrual cycle: the relationship between hormones, sexuality, and mood","volume":"26","author":"Van Goozen","year":"1997","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.steroids.2020.108748_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2011.03.061","article-title":"Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons","volume":"191","author":"B\u00e4ckstr\u00f6m","year":"2011","journal-title":"Neurosci."},{"key":"10.1016\/j.steroids.2020.108748_b0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bpobgyn.2016.04.001","article-title":"Ethnic differences: Is there an Asian phenotype for polycystic ovarian syndrome ?","volume":"37","author":"Huang","year":"2016","journal-title":"Best. Practice. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.steroids.2020.108748_b0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eem.12.73","article-title":"Ethnic-specific polycystic ovary syndrome: epidemiology, significance and implications","volume":"8","author":"Wijeyaratne","year":"2013","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2020.108748_b0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20301744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20301744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:05:19Z","timestamp":1758535519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X20301744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"alternative-id":["S0039128X20301744"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108748","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating steroids and mood disorders in patients with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108748"}}